U.S. General Merchandise and Department Stores Stock News

ZTO Express (Cayman) (ZTO) is back in focus after Zacks raised its consensus estimate for the company’s current year earnings by 6.8% over the past two months, highlighting its income profile. See our latest analysis for ZTO Express (Cayman). At a share price of US$23.22, ZTO Express (Cayman) has posted an 8.20% year to date share price return and a 35.23% total shareholder return over the past year. The recent 30 day share price gain of 5.07% contrasts with a 90 day decline of 5.11%,...

Casella Waste Systems has appointed Damian Ribar as Executive Vice President and Chief Operating Officer, effective July 20, 2026, and promoted longtime legal leader Shelley Sayward to Executive Vice President and General Counsel, expanding its senior leadership bench. These moves bring in a seasoned operator with deep acquisition-integration experience while elevating a key internal leader who oversees legal, regulatory, and risk functions central to Casella’s expansion plans. We’ll now...

T. Rowe Price Investment Management disclosed in a recent Schedule 13G/A filing that it owns about 10.2% of Denali Therapeutics’ outstanding shares, with sole voting power over most of the stake. This sizable institutional position comes shortly after Denali secured FDA approval for its lead Hunter syndrome therapy Avlayah and sold a Rare Pediatric Disease Priority Review Voucher for US$195,000,000, highlighting growing institutional interest alongside new commercial and funding...

Insiders who acquired US$2.65m worth of The Metals Royalty Company Inc.'s ( NASDAQ:TMCR ) stock at an average price of...

First Watch Restaurant Group, Inc. ( NASDAQ:FWRG ), might not be a large cap stock, but it saw a significant share...

Over the last 7 days, the United States market has remained flat, yet it has experienced an impressive 18% growth over the past year with earnings forecasted to grow by another 18% annually. In this environment, identifying stocks that are potentially undervalued compared to their intrinsic value can offer investors opportunities for growth that align with these optimistic market conditions.

The market remained flat over the last week, but has shown a robust 18% increase over the past year, with earnings projected to grow by the same percentage annually. In this environment, identifying growth companies with substantial insider ownership can be particularly appealing as it often signals confidence from those closest to the business.

In the last week, the market has stayed flat, though it is up 18% over the past year and earnings are forecast to grow by 18% annually. Penny stocks may be a throwback term, but the opportunities they represent are far from old news. These smaller or newer companies can offer growth potential at lower price points, especially when backed by strong financial health and solid fundamentals.

In the last week, the United States market has stayed flat, but over the past 12 months, it has risen by an impressive 18%, with earnings forecasted to grow annually at a similar rate. In this environment, dividend stocks that offer substantial yields can be appealing for investors seeking consistent income alongside potential capital appreciation.

The recent price decline of 11% in Bonk, Inc.'s ( NASDAQ:BNKK ) stock may have disappointed insiders who bought...

Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) value has fallen 12% in the last week, but insiders who sold US$220k worth...

Fastly stock has surged over the past year, yet the valuation signals are split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while market based multiples suggest the shares already trade at a premium. Fastly has delivered a 178.0% return over the past year, which puts extra focus on whether that rerating is supported by the underlying value of the business. The recent partnership with Skyfire can support expectations for Fastly's edge cloud and...

Medical Properties Trust's Swiss hospital real estate affiliate, Infracore, is set to list on the SIX Swiss Exchange. As part of the IPO, Medical Properties Trust plans to sell a portion of its Infracore shares. The company intends to use proceeds from the sale to repay debt and improve liquidity. Medical Properties Trust (NYSE:MPT) is drawing fresh attention as it prepares for the public listing of Infracore on the SIX Swiss Exchange. The stock recently closed at $4.48, with the share...

Curbline Properties (CURB) recently completed a follow on equity offering, issuing 10,000,000 common shares for total proceeds of $308.5 million. This transaction reshapes its capital base and potential dilution profile. See our latest analysis for Curbline Properties. Since listing, Curbline Properties has seen solid momentum, with a year to date share price return of 31.86% and a 1 year total shareholder return of 40.88%. The recent follow on offering price of $30.85 sits close to the...

Encompass Health stock sits at a point where a solid 5 year return record meets a valuation setup that screens as attractively priced, with both intrinsic value estimates using a Discounted Cash Flow (DCF) approach and market multiples pointing to the shares trading below what the cash flows may justify. Over the past 5 years, Encompass Health has returned 83.0%, which puts recent short term swings into the context of a stock that has already rewarded patient holders. Investor interest tied...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

AMC Entertainment Holdings (NYSE:AMC) is launching Arena One, a live concerts platform, across more than 300 U.S. theaters. The rollout turns AMC locations into multi-purpose venues, hosting live music events in addition to traditional movie screenings. The company is positioning Arena One as a way to broaden its entertainment offering and open up additional revenue channels. AMC Entertainment Holdings is known primarily for its movie theaters, but Arena One signals a push to use those...

Insight Enterprises stock is up 34.0% year to date, yet the valuation picture is more balanced, with a Discounted Cash Flow (DCF) intrinsic value estimate that sits close to the current price while earnings-based multiples still screen the shares as undervalued. The 34.0% year to date gain suggests investors have already repriced Insight Enterprises positively, so any further upside may depend on how much earnings and cash flow can improve from here. Expectations for ongoing cash generation...

SPX Technologies stock has delivered a very strong 235.7% return over the past five years, yet the valuation signals are split, with a Discounted Cash Flow (DCF) estimate pointing to roughly 23.2% upside to intrinsic value while earnings multiples paint a richer picture. Over five years, SPX Technologies has returned 235.7%, which puts extra focus on whether the recent share price now builds in most of the good news. Growing data center cooling demand in the HVAC segment can support higher...

Waters Corporation (NYSE:WAT) has expanded its role in at-home cervical cancer screening through the acquisition of BD Biosciences and BD Diagnostic Solutions. The acquired diagnostics and biosciences platforms are now enabling SNT Biotech's nationwide self-collection solution for cervical cancer tests. This move connects Waters' lab and diagnostics capabilities directly to a public health initiative aimed at improving access for underserved populations. Waters enters this development with...

Markets are wrestling with a split Federal Reserve, persistent inflation risks, and a new leadership style that offers far less guidance, which can punish companies that rely on cheap capital and reward those with sturdier balance sheets. Against that backdrop, data center infrastructure and semiconductor hardware stocks tied to artificial intelligence sit right in the crosshairs of policy uncertainty and heavy corporate investment. This article looks at 3 stocks from our AI and Data Center...

Teva Pharmaceutical Industries (NYSE:TEVA) is advancing TEV-408, an anti-IL-15 monoclonal antibody for vitiligo, into a Phase 2b trial following encouraging Phase 1b data. The Phase 1b study reported improvements in skin pigmentation along with a favorable safety profile, supporting continued development. The move targets an area where systemic treatment choices for vitiligo remain limited, addressing a clear medical need. For investors tracking Teva Pharmaceutical Industries, the focus now...

Klarna Group (NYSE:KLAR) has partnered with Flix to offer flexible payment options for bus and rail bookings. The company has also partnered with Southwest Airlines to bring its pay-over-time services to a major U.S. carrier. Klarna has applied for a U.S. industrial banking license, seeking to bring more of its American banking operations in-house. Klarna Group enters this phase of expansion with its stock trading at $19.03 and a mixed recent record. The share price is up 15.0% over the...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...